Diabetes Clinical Trials in Illinois

Showing 21-40 of 608 trials

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

NCT06851858

This Phase II study is a randomized, parallel group, double blinded, placebo-controlled, multicenter to evaluate the efficacy, safety, and tolerability of AZD6234 in adults with overweight or obesity and type 2 diabetes on stable GLP-1 RA therapy.

EndocrinologyDiabetes, Type IIObesity

AstraZeneca69 participantsStarted Mar 2025

Birmingham, Alabama, United States • Mobile, Alabama, United States • Doral, Florida, United States +15 more locations

RECRUITINGPhase 2125 miles

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

NCT07296484

CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors for trial eligibility and the presence of elevated cortisol. Participants deemed eligible from Part 1 will be randomized to either clofutriben or placebo in the double-blind (participant and investigator), dose-ranging, interventional Part 2 (Treatment).

Type 2 DiabetesCortisol Excess

Sparrow Pharmaceuticals1,500 participantsStarted Nov 2025

Chandler, Arizona, United States • Tucson, Arizona, United States • Fountain Valley, California, United States +43 more locations

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Diabetes Trials in Other Cities

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

The PIVOT Trial: Project on EHR-Integrated Lifestyle Interventions for Adults Aged Fifty and Older

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

Type 1 Diabetes Extension Study

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

Siplizumab in T1DM

Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

Closed Loop and Education for Hypoglycemia Awareness Restoration

Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)

Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment

Other Conditions in Illinois